Day: February 4, 2025

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on Tuesday, February 11, 2025 at 10:40 a.m. ET.   A webcast of Sensei’s presentation will be available in the Investors section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event. Registration for the webcast is available here. About Sensei Biotherapeutics  Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on February 11-12, 2025. Details are as follows:Oppenheimer’s 35th Annual Healthcare Life Sciences ConferenceConference Date:   February 11-12, 2025Format:   Company Presentation and one-on-one meetingsPresentation Time:   Tuesday, February 11, 2025, 4:00 to 4:30 PM ETWebcast Link:   https://wsw.com/webcast/oppenheimer39/imab/2739496 About I-Mab I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology...

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held virtually, February 11-12, 2025. Owen Hughes, Chief Executive Officer, and Brad Sitko, Chief Investment Officer, will participate in a fireside chat on Tuesday, February 11, 2025 at 3:20 PM ET. The presentation can be assessed by visiting https://bit.ly/4jAMqQw. XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com.  A replay of each presentation will be available and archived on the site for 90 days after the event. About XOMA Royalty CorporationXOMA Royalty is a biotechnology royalty aggregator...

Shelton, CT, Feb. 04, 2025 (GLOBE NEWSWIRE) — HUBBELL REPORTS FOURTH QUARTER 2024 AND FULL YEAR RESULTSQ4 diluted EPS of $3.64; adjusted diluted EPS of $4.10 (up 11% y/y) Q4 net sales -1% (organic -3%; net M&A +3%) Q4 operating margin 19.3%; adjusted operating margin 21.8% (up 240bps y/y) FY 2024 diluted EPS of $14.37; adjusted diluted EPS of $16.57 FY 2025 diluted EPS expected range of $16.00-$16.50; adj. diluted EPS of $17.35-$17.85SHELTON, CT. (February 4, 2025) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2024. “Hubbell delivered double-digit growth in operating profit, earnings per share and free cash flow in the fourth quarter” said Gerben Bakker, Chairman, President and CEO. “While organic growth was below our expectations in...

MIAMI, Feb. 04, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, will hold a conference call on Thursday, March 6, 2025, at 8:30 a.m. ET to discuss results for the fourth quarter and full year ended December 31, 2024. AYR Interim CEO Steven Cohen and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call. Date: Thursday, March 6, 2025Time: 8:30 a.m. ETToll-free dial-in number: (844) 763-8274International dial-in number: (647) 484-8814Webcast: LINK A telephonic replay of the conference call will also be available for one month until end of day Sunday, April 6, 2025. Toll-free replay number: (877) 344-7529International...

CALGARY, Alberta, Feb. 04, 2025 (GLOBE NEWSWIRE) — Tornado Infrastructure Equipment Ltd. (“Tornado”, the “Company” or “we”) (TSX-V: TGH; OTCQX: TGHLF) is pleased to announce the launch of Tornado Equipment Finance Ltd. (“Tornado Finance”), a dedicated financing arm designed to provide financing, rental, and leasing solutions to support its customers’ equipment needs across Canada. Launch of Tornado Finance Tornado Finance will offer flexible financial solutions exclusively to Canadian customers, making it easier for businesses to acquire Tornado’s industry-leading hydrovac trucks and infrastructure equipment. By providing in-house financing options, Tornado aims to enhance customer accessibility while strengthening long-term relationships. The Company expects this new initiative to generate a steady additional revenue stream...

WATERLOO, Ontario and ATLANTA, Feb. 04, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its fiscal 2024 fourth-quarter and year-end financial results after market close on Wednesday, March 5, 2025. Descartes’ executive management team will hold a conference call to discuss the company’s financial results at 5:30 PM ET on Wednesday, March 5. Designated numbers are +1 289 514 5100 or +1 800 717 1738 for North America Toll-Free, using Passcode 45440#. The company will simultaneously conduct an audio webcast on the Descartes website at www.descartes.com/descartes/investor-relations. Phone conference dial-in or webcast login is required approximately 10 minutes beforehand. Replays of the conference call...